Oxygen as a driving gas for nebulisers: safe or dangerous?
- PMID: 6419892
- PMCID: PMC1444033
- DOI: 10.1136/bmj.288.6413.272
Oxygen as a driving gas for nebulisers: safe or dangerous?
Abstract
Changes in blood gas tensions occurring when 100% oxygen or air was used as the driving gas for nebulised salbutamol were studied in 23 patients with severe airways obstruction. The patients fell into three groups: nine had chronic bronchitis and emphysema with carbon dioxide retention, seven had emphysema and chronic bronchitis without carbon dioxide retention, and seven had severe asthma (no carbon dioxide retention). When oxygen was used as the driving gas patients who retained carbon dioxide showed a mean rise of 1.03 kPa (7.7 mm Hg) in their pressure of carbon dioxide (Pco2) after 15 minutes (p less than 0.001) but the Pco2 returned to baseline values within 20 minutes of stopping the nebuliser. The other two groups showed no rise in Pco2 with oxygen. When air was used as the driving gas none of the groups became significantly more hypoxic. Although it is safe to use oxygen as the driving gas for nebulisers in patients with obstructive airways disease with normal Pco2, caution should be exercised in those who already have carbon dioxide retention.
Similar articles
-
Air or oxygen as driving gas for nebulised salbutamol.Arch Dis Child. 1988 Aug;63(8):900-4. doi: 10.1136/adc.63.8.900. Arch Dis Child. 1988. PMID: 3046513 Free PMC article. Clinical Trial.
-
Arterial blood gas measurements in the management of patients with chronic bronchitis and emphysema.Thorax. 1957 Sep;12(3):236-40. doi: 10.1136/thx.12.3.236. Thorax. 1957. PMID: 13467882 Free PMC article. No abstract available.
-
Almitrine improves oxygenation when both awake and asleep in patients with hypoxia and carbon dioxide retention caused by chronic bronchitis and emphysema.Am Rev Respir Dis. 1985 Aug;132(2):206-10. doi: 10.1164/arrd.1985.132.2.206. Am Rev Respir Dis. 1985. PMID: 4026044 Clinical Trial.
-
Acute respiratory failure in chronic obstructive pulmonary disease. I. Pathophysiology.Dis Mon. 1969 Oct:3-37. Dis Mon. 1969. PMID: 4901502 Review. No abstract available.
-
Nebulized bronchodilators in obstructive lung disease. II.Ann Allergy. 1972 Feb;30(2):69-85. Ann Allergy. 1972. PMID: 4551435 Review. No abstract available.
Cited by
-
Nebulizer therapy. Guidelines. British Thoracic Society Nebulizer Project Group.Thorax. 1997 Apr;52 Suppl 2(Suppl 2):S4-24. doi: 10.1136/thx.52.2008.s4. Thorax. 1997. PMID: 9155847 Free PMC article. No abstract available.
-
Adverse reactions to beta 2-agonist bronchodilators.Med Toxicol. 1986 Jul-Aug;1(4):286-99. doi: 10.1007/BF03259844. Med Toxicol. 1986. PMID: 2878344 Review.
-
Audit of nebuliser use.Postgrad Med J. 1985 Dec;61(722):1055-6. doi: 10.1136/pgmj.61.722.1055. Postgrad Med J. 1985. PMID: 4095048 Free PMC article.
-
Oxygen versus air-driven nebulisers for exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial.BMC Pulm Med. 2018 Oct 3;18(1):157. doi: 10.1186/s12890-018-0720-7. BMC Pulm Med. 2018. PMID: 30285695 Free PMC article. Clinical Trial.
-
Use of oxygen driven nebulizer delivery systems for beta-2 agonists in chronic bronchitis.Ir J Med Sci. 1985 May;154(5):198-200. doi: 10.1007/BF02937361. Ir J Med Sci. 1985. PMID: 4030280 No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources